Applied Materials(AMAT) - 2026 Q1 - Earnings Call Transcript
2026-02-12 22:32
Applied Materials (NasdaqGS:AMAT) Q1 2026 Earnings call February 12, 2026 04:30 PM ET Company ParticipantsBlayne Curtis - Managing DirectorBrice Hill - CFOCJ Muse - Senior Managing DirectorGary Dickerson - CEOHarlan Sur - Executive Director of Equity ResearchKrish Sankar - Managing DirectorMark Lipacis - Senior Managing DirectorMelissa Weathers - Director of Equity ResearchMike Sullivan - Corporate VP of Investor RelationsTimothy Arcuri - Managing DirectorVivek Arya - Managing DirectorConference Call Partic ...
AVITA Medical(RCEL) - 2025 Q4 - Earnings Call Transcript
2026-02-12 22:32
AVITA Medical (NasdaqCM:RCEL) Q4 2025 Earnings call February 12, 2026 04:30 PM ET Company ParticipantsBen Atkins - VP of Investor RelationsCary Vance - Interim CEODavid O'Toole - CFOConference Call ParticipantsIan Arndt - Equity Research AnalystJosh Jennings - Equity Research AnalystRyan Zimmerman - Equity Research AnalystOperatorday, and thank you for standing by. Welcome to the AVITA Medical, Inc. fourth quarter and full-year 2025 earnings conference call. At this time, all participants are in listen-only ...
Forrester Research(FORR) - 2025 Q4 - Earnings Call Transcript
2026-02-12 22:32
Financial Data and Key Metrics Changes - In Q4 2025, revenue declined by 6% year-over-year to $101.1 million, while full-year revenue decreased by 8% to $396.9 million compared to $432.5 million in 2024 [20][28] - Free cash flow for 2025 was approximately $18 million, with client retention reaching 87%, up from the start of 2025 [10][29] - Net income for Q4 decreased by 53% to $3.2 million, with earnings per share at $0.17, while full-year net income decreased by 21% to $22.2 million [28][31] Business Line Data and Key Metrics Changes - Research segment revenue for Q4 was $76.6 million, down 4% year-over-year, and $295.6 million for the full year, a decline of 7% [25] - Consulting revenue for Q4 was $21.8 million, down 16%, and $88.2 million for the full year, a decline of 9% [26] - Events revenue for Q4 was $2.7 million, a decline of 1%, and for the full year, it decreased by 29% to $13.1 million [26] Market Data and Key Metrics Changes - Client count increased in Q4 for the first time since Q4 2021, reflecting a positive trend in client engagement [10] - The percentage of contract value (CV) from multi-year deals increased to 72% at year-end, up from 69% in Q4 2024 [10] Company Strategy and Development Direction - The company is focusing on four initiatives for 2026: improving retention lifecycle execution, introducing more product options, fostering a culture of growth in sales, and producing actionable research [11][12] - A restructuring plan affecting 8% of employees was announced to align costs with revenue and focus on expanding research contract value [16][22] - The strategy consulting business will be exited due to ongoing instability and competition, while advisory services will continue [21][22] Management's Comments on Operating Environment and Future Outlook - Management noted that clients are navigating a new paradigm shaped by AI, with increasing complexity in decision-making and technology challenges [6][7] - The company expressed optimism about returning to CV growth in 2026, driven by improvements in client retention and the success of the new AI Access product [11][19] - Management acknowledged ongoing macro uncertainties and the impact of the U.S. government's consulting pullback on performance [20][31] Other Important Information - The company plans to enhance its AI capabilities and expand its product offerings, including a rebranding of its flagship AI tool to Forrester AI [13][19] - The new event strategy will focus on smaller, localized events to better meet client needs [17][53] Q&A Session Summary Question: Can you elaborate on the consulting restructure and expected revenue impact? - The revenue impact from sunsetting strategy consulting is approximately $6 million, with a backlog of about $8 million to service throughout 2026 [36] Question: What are the reasons for lower wallet retention? - Management indicated that volatility in the U.S. government sector and uncertainties in the U.S. business are contributing factors [38][39] Question: Can you discuss the product pipeline for the year? - The company is looking to provide more ways for clients to engage and embed Forrester's offerings into their daily work [47][48] Question: How is AI Access performing versus expectations? - AI Access exceeded expectations in Q4, with a strong pipeline and positive client engagement [72][78] Question: Will there be changes in the sales process with new leadership? - The sales strategy will be reorganized around six industries, focusing on high-potential accounts and improving retention lifecycle execution [68][71]
Warrior Met Coal(HCC) - 2025 Q4 - Earnings Call Transcript
2026-02-12 22:32
Warrior Met Coal (NYSE:HCC) Q4 2025 Earnings call February 12, 2026 04:30 PM ET Company ParticipantsBrian Chopin - Chief Accounting Officer and ControllerChris LaFemina - Managing Director and Global Head of Metals and Mining Equity ResearchDale Boyles - CFOKatja Jancic - Director of Metals and Mining ResearchWalt Scheller - CEOConference Call ParticipantsGeorge Eadie - Mining AnalystNathan Martin - Senior Equity Research AnalystNick Giles - Senior Research AnalystOperatorGood afternoon. My name is Chris, a ...
Alliance Entertainment (AENT) - 2026 Q2 - Earnings Call Transcript
2026-02-12 22:32
Alliance Entertainment (NasdaqCM:AENT) Q2 2026 Earnings call February 12, 2026 04:30 PM ET Company ParticipantsAmanda Gnecco - CFOJeff Walker - CEOPaul Kuntz - Investor Relations RepresentativeConference Call ParticipantsMichael Kupinski - Director of Research and Senior Media & Entertainment AnalystThomas Forte - Managing Director and Senior Consumer Internet AnalystOperatorGreetings, and welcome to Alliance Entertainment's second quarter fiscal year 2026 financial results conference call. At this time, al ...
Legacy Education Inc.(LGCY) - 2026 Q2 - Earnings Call Transcript
2026-02-12 22:32
Financial Data and Key Metrics Changes - Revenue grew 40.7% year-over-year to $19.2 million, marking the fourteenth consecutive quarter of double-digit revenue growth [7][15] - Adjusted EBITDA increased 61.6% to $3 million, reflecting scale and effective cost management [8][15] - Net income rose 46% to $2 million, or $0.15 per diluted share, up from $0.10 in the prior year quarter [8][16] - Year-to-date revenue for six months ended December 31, 2025, grew 39.6% to $38.6 million [18] Business Line Data and Key Metrics Changes - New student starts increased by 49.4% to 593 from 397 last year, driven by strong enrollment and disciplined marketing execution [15][16] - Enrollment at Contra Costa Medical Career College reached all-time highs of over 500 students [10] Market Data and Key Metrics Changes - The healthcare occupation sector is projected to be the fastest-growing major industry from 2024 to 2034, with about 1.9 million openings projected each year on average [5][6] Company Strategy and Development Direction - The company is focused on scaling quality, improving outcomes, and training job-ready graduates for essential roles in healthcare [5][7] - Strategic priorities include sustained enrollment growth, curriculum expansion, and operational innovation [21][23] - The company is pursuing additional regulatory approvals and evaluating accretive acquisitions to enhance growth [23][24] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's trajectory and operational execution, emphasizing the importance of maintaining high standards in curriculum and compliance [11][25] - The company is well-positioned to navigate regulatory changes and is focused on delivering strong outcomes for students [25][26] Other Important Information - The company has a strong balance sheet with $21.1 million in cash and little debt at $600,000 [19] - The effective tax rate increased to 28.9% from 27.3% due to fluctuations in stock option exercises [16] Q&A Session Summary Question: Discussion on new student starts - Management noted that the robust new student starts were driven by additional cohorts in hybrid programs and strong performance in vocational nursing and surgical tech programs [28][29] Question: Outlook on new program launches - Management confirmed optimism about new program launches in Q3 and Q4, including cardiac sonography and MRI programs [31][32] Question: Acquisition pipeline and geographic expansion - Management indicated that they are exploring acquisition opportunities both within and outside California, focusing on multi-campus opportunities [46][47] Question: Hybrid program structure and student commitments - Management clarified that hybrid programs require full-time commitment, with students balancing online theory and in-person lab sessions [50][51] Question: Revenue per student and program performance - Management explained that the increase in revenue per student is attributed to more students entering higher-margin programs and the impact of new enrollments [55]
Artivion(AORT) - 2025 Q4 - Earnings Call Transcript
2026-02-12 22:32
Artivion (NYSE:AORT) Q4 2025 Earnings call February 12, 2026 04:30 PM ET Company ParticipantsBill Plovanic - Managing Director and Healthcare Equity ResearchDaniel Stauder - VP of Equity ResearchLance Berry - COO and CFOLane Morgan - Associate Vice PresidentPat Mackin - CEOConference Call ParticipantsJohn McCalley - Equity Research AnalystMike Matson - Managing Director and Senior Equity Research AnalystNone - AnalystNone - AnalystOperatorGood afternoon, and welcome to the Artivion Q4 and Year-end 2025 Earn ...
Sensus Healthcare(SRTS) - 2025 Q4 - Earnings Call Transcript
2026-02-12 22:32
Sensus Healthcare (NasdaqCM:SRTS) Q4 2025 Earnings call February 12, 2026 04:30 PM ET Company ParticipantsAnthony Vendetti - Executive Managing DirectorBen Haynor - Managing Director of Medical Technology ResearchJavier Rampolla - CFOJoe Sardano - Chairman and CEOMichael Sardano - President & Chief Commercial OfficerTirth Patel - VPOperatorGood afternoon, and welcome to the Sensus Healthcare Fourth Quarter and Full Year 2025 Financial Results Conference Call. All participants will be in listen-only mode. Sh ...
Applied Materials(AMAT) - 2026 Q1 - Earnings Call Transcript
2026-02-12 22:32
Applied Materials (NasdaqGS:AMAT) Q1 2026 Earnings call February 12, 2026 04:30 PM ET Company ParticipantsBlayne Curtis - Managing DirectorBrice Hill - CFOCJ Muse - Senior Managing DirectorGary Dickerson - CEOHarlan Sur - Executive Director of Equity ResearchKrish Sankar - Managing DirectorMark Lipacis - Senior Managing DirectorMelissa Weathers - Director of Equity ResearchMike Sullivan - Corporate VP of Investor RelationsTimothy Arcuri - Managing DirectorVivek Arya - Managing DirectorConference Call Partic ...
Cohu(COHU) - 2025 Q4 - Earnings Call Transcript
2026-02-12 22:32
Financial Data and Key Metrics Changes - Fourth quarter revenue reached $122 million, a 30% increase year-over-year, with 40% from systems and 60% from recurring revenue [5][10] - Full year revenue for 2025 was $453 million, up 13% year-over-year, indicating a market recovery trajectory [6][10] - Gross margin for Q4 was 40.8%, lower than guidance due to one-time inventory charges [11] - Cash and investments increased by $286 million during Q4, totaling $484 million at year-end [12] Business Line Data and Key Metrics Changes - Recurring revenue grew 4% quarter-over-quarter and 25% year-over-year, representing about 60% of total revenue in Q4 [4][5] - Systems demand increased 47% quarter-over-quarter, driven by higher equipment orders from major global customers [4] - The top ten customers accounted for approximately 63% of Q4 bookings, indicating healthy diversification [5] Market Data and Key Metrics Changes - Test utilization trends improved, with estimated utilization at 76% by the end of December, with computing at 78% and automotive at 75% [7] - Increased activity noted in automotive and industrial semiconductor sectors, alongside strong demand from RF and connectivity device customers [4][9] Company Strategy and Development Direction - The company is focusing on high-performance computing, HBM memory, and AI-related high-growth opportunities [11][12] - A strategic convertible notes offering was completed to strengthen the balance sheet and support strategic initiatives [12] - The company aims to support R&D investments enabling design wins in compute markets, including AI data center infrastructure [15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating regional shifts and aligning with customers investing in long-term technology transitions [9] - The outlook for Q1 2026 anticipates revenue to be seasonally flat with Q4, with recurring revenue expected to represent about 60% of total revenue [14] - Management expects continued growth in 2026, building on the 13% revenue growth in 2025 [35] Other Important Information - The company secured significant orders for new products, including a high-performance thermal configuration of the Eclipse handler and a multi-unit order for a new handler targeting automotive and AI device tests [8][9] - The company has a solid risk balance profile due to low direct exposure to China and strong customer diversification across North America, Europe, and Asia [9] Q&A Session Summary Question: Order activity in Q4 - Management noted systems orders were up 47% quarter-over-quarter, with recurring orders up 34% quarter-over-quarter, indicating strong demand [18][20] Question: Revenue from Neon high bandwidth memory - The company exited 2025 with $11 million in HBM revenue and forecasts $15 million to $20 million for 2026 [22] Question: Eclipse activity and capacity - Management confirmed capacity to meet demand for the Eclipse handler, with expectations for increased shipments in the second quarter [25][26] Question: Customer activity changes - Management observed increased demand from traditional customers and strong forecasts for the Eclipse product line in compute and mobile applications [34] Question: IDM vs. OSAT performance - Utilization rates for IDMs were slightly higher than OSATs in Q4, with expectations that OSATs may see faster growth in the first quarter [50]